Evidence map›Paper›PMID 27571976›Full record

ArticleNature microbiology2016

pks5-recombination-mediated surface remodelling in Mycobacterium tuberculosis emergence.

Eva C Boritsch, Wafa Frigui, Alessandro Cascioferro, Wladimir Malaga, Gilles Etienne, Françoise Laval, Alexandre Pawlik, Fabien Le Chevalier, Mickael Orgeur, Laurence Ma and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Smooth-to-rough morphotype alterations inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Population heterogeneity inMicrobiology (Reading, England) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Frontiers in immunology · 2022
    Article
  16. Elimination of PknL and MSMEG_4242 inCell surface (Amsterdam, Netherlands) · 2021
    Article
  17. Article
  18. Insights into the ancestry evolution of theNAR genomics and bioinformatics · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Eva C BoritschInstitut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, Paris 75015, France.
Wafa FriguiInstitut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, Paris 75015, France.
Alessandro CascioferroInstitut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, Paris 75015, France.
Wladimir MalagaCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse 31000, France.
Gilles EtienneCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse 31000, France.
Françoise LavalCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse 31000, France.
Alexandre PawlikInstitut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, Paris 75015, France.
Fabien Le ChevalierInstitut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, Paris 75015, France.
Mickael OrgeurInstitut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, Paris 75015, France.
Laurence MaInstitut Pasteur, PF1-Plate-Forme Génomique, Paris, France.
Christiane BouchierInstitut Pasteur, PF1-Plate-Forme Génomique, Paris, France.
Timothy P StinearDepartment of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0003-0150-123X
Philip SupplyInserm U1019, CNRS UMR8204, Université de Lille, Institut Pasteur de Lille, Center for Infection and Immunity, Lille 59000, France.
Laleh MajlessiInstitut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, Paris 75015, France.
Mamadou DafféCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse 31000, France.
Christophe GuilhotCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Toulouse 31000, France.
Roland BroschInstitut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, Paris 75015, France.ORCID http://orcid.org/0000-0003-2587-3863
Institut Pasteur · FRCentre National de la Recherche Scientifique · FRThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium tuberculosis is a major, globally spread, aerosol-transmitted human pathogen, thought to have evolved by clonal expansion from a Mycobacterium canettii-like progenitor. In contrast, extant M. canettii strains are rare, genetically diverse, and geographically restricted mycobacteria of only marginal epidemiological importance. Here, we show that the contrasting evolutionary success of these two groups is linked to loss of lipooligosaccharide biosynthesis and subsequent morphotype changes. Spontaneous smooth-to-rough M. canettii variants were found to be mutated in the polyketide-synthase-encoding pks5 locus and deficient in lipooligosaccharide synthesis, a phenotype restored by complementation. Importantly, these rough variants showed an altered host-pathogen interaction and increased virulence in cellular- and animal-infection models. In one variant, lipooligosaccharide deficiency occurred via homologous recombination between two pks5 genes and removal of the intervening acyltransferase-encoding gene. The resulting single pks5 configuration is similar to that fixed in M. tuberculosis, which is known to lack lipooligosaccharides. Our results suggest that pks5-recombination-mediated bacterial surface remodelling increased virulence, driving evolution from putative generalist mycobacteria towards professional pathogens of mammalian hosts.

Indexed as

Biosynthetic PathwaysEvolution, MolecularAnimalsDisease Models, AnimalGene DeletionGenetic Complementation TestHomologous RecombinationHost-Pathogen InteractionsHumansLipopolysaccharidesMiceMycobacteriumMycobacterium InfectionsPolyketide SynthasesVirulencelipid-linked oligosaccharidesLipopolysaccharidesPolyketide Synthases

Identifiers

PMID27571976
OpenAlexW2272836913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.